Research
Title : | Design, validation, and development of novel peptidomimetic therapeutics targeting SARS-CoV-2 replication |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology |
Focus area : | COVID-19 Diagnostics |
Principal Investigator : | Dr Arockiasamy Arulandu, Group Leader, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi |
Timeline Start Year : | 2020 |
Contact info : | asamy001@gmail.com |
Details
Executive Summary : | The aim of this study is to deliver novel peptidomimetic inhibitors targeting Mpro and PLpro with therapeutic potential, validated in vitro and in vivo using recent animal models for SARS-CoV-2. |
Organizations involved
Implementing Agency : | International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi Funding Agency :Department of Science and Technology (DST), Govt of India | |